Clinical trials: Sitosterolemia
Cardiovascular Disease
Cholesterol Metabolism in Heterozygous Phytosterolemia
The purpose of the study is to examine the effect of plant sterols on cholesterol absorption and synthesis in people with heterozygous phytosterolemia.
- Trial name
- NCT01102647
- Testing
- phytosterol ester
- Where
- Canada
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- University of Manitoba
Sitosterolemia
Sitosterolemia Metabolism
Ezetimibe has become the treatment choice for patients with sitosterolemia. Ezetimibe is an inhibitor of cholesterol absorption from the gastrointestinal tract.
- Trial name
- STAIR7002 (NCT01584206)
- Testing
- Ezetimibe
- Where
- Canada
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- University of Manitoba
Lipid Metabolism, Inborn Errors, Sitosterolemia
Genetic Study of Sitosterolemia
OBJECTIVES: I. Identify the genetic defect and fine map the gene that causes sitosterolemia.
- Trial name
- NCT00004481
- Testing
- genetic testing
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- National Center for Research Resources (NCRR)